PNR
53
3
ROST
61
5
WBA
43
-5
ZTS
34
5
DHI
35
4
TJX
42
5
GRMN
52
6
BWA
38
-6
D
53
5
ABBV
51
-4
COF
47
-2
PHM
43
6
ICE
45
3
UHS
60
4
ETR
71
2
ALL
43
6
HRB
37
2
AES
39
-2
MA
46
2
AIZ
52
2
PNR
53
3
ROST
61
5
WBA
43
-5
ZTS
34
5
DHI
35
4
TJX
42
5
GRMN
52
6
BWA
38
-6
D
53
5
ABBV
51
-4
COF
47
-2
PHM
43
6
ICE
45
3
UHS
60
4
ETR
71
2
ALL
43
6
HRB
37
2
AES
39
-2
MA
46
2
AIZ
52
2
Financhill
Back

FlexShares Credit-Scored US Corp Bond Index Fund Vs. Janux Therapeutics Industry Stock Comparison

Sell
38

SKOR
FlexShares Credit-Scored US Corp Bond Index Fund

Last Price:
$47.63
Seasonality Move:
-0.57%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
38
FlexShares Credit-Scored US Corp Bond Index Fund (SKOR) is a Sell

Is FlexShares Credit-Scored US Corp Bond Index Fund a Buy, Sell or Hold?

  • The current FlexShares Credit-Scored US Corp Bond Index Fund [SKOR] share price is $47.60. The Score for SKOR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • SKOR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SKOR Stock Price Chart

What is FlexShares Credit-Scored US Corp Bond Index Fund's stock price today?

  • The FlexShares Credit-Scored US Corp Bond Index Fund share price today is $47.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKOR is experiencing slight buying pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

SKOR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 33.46 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.66 - 48.26) Sell
Bollinger Bands (100): (47.96 - 48.88) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

SKOR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.67 Sell
20-day SMA: 47.87 Sell
50-day SMA: 48.04 Sell
200-day SMA: 47.97 Sell
8-day EMA: 47.68 Sell
20-day EMA: 47.82 Sell
50-day EMA: 48.04 Sell
200-day EMA: 47.99 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

FlexShares Credit-Scored US Corp Bond Index Fund Earnings Growth & SKOR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

FlexShares Credit-Scored US Corp Bond Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):